Chad Messer
Stock Analyst at Lake Street
(0.55)
# 3,787
Out of 4,829 analysts
23
Total ratings
34.78%
Success rate
-26.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.98 | +528.14% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $7.46 | +208.31% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.95 | +874.36% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $0.80 | +14,182.13% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $10.15 | +392.61% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $31.70 | +51.44% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $36.17 | -17.06% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $27.87 | +79.40% | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | $31 → $29 | $11.66 | +148.71% | 2 | May 14, 2021 | |
| MREO Mereo BioPharma Group | Initiates: Buy | $10 | $2.41 | +314.94% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $32.30 | +166.30% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.88 | +8,422.73% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $9.50 | +363.16% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $36.27 | +357.68% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $2.55 | +605.88% | 1 | May 5, 2020 |
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.98
Upside: +528.14%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $7.46
Upside: +208.31%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.95
Upside: +874.36%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $0.80
Upside: +14,182.13%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $10.15
Upside: +392.61%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $31.70
Upside: +51.44%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $36.17
Upside: -17.06%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $27.87
Upside: +79.40%
CorMedix
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $11.66
Upside: +148.71%
Mereo BioPharma Group
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $32.30
Upside: +166.30%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $0.88
Upside: +8,422.73%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $9.50
Upside: +363.16%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $36.27
Upside: +357.68%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $2.55
Upside: +605.88%